Hypercholesterolemia Trials in Berlin, Germany
Conditions / Hypercholesterolemia / Berlin, Germany
Research into Hypercholesterolemia spans multiple therapeutic approaches and trial phases.
30 total trials for this combination
Showing top 10 of 30 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06492291 | Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04271280 | Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events | COMPLETED | — |
| NCT05192941 | Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia | COMPLETED | — |
| NCT01507831 | Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term) | COMPLETED | PHASE3 |
| NCT01954394 | Open Label Study of Long Term Safety Evaluation of Alirocumab | COMPLETED | PHASE3 |
| NCT05952856 | A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids | COMPLETED | PHASE3 |
| NCT01439880 | Open Label Study of Long Term Evaluation Against LDL-C Trial | COMPLETED | PHASE2 |
| NCT01730040 | Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I) | COMPLETED | PHASE3 |
| NCT01475825 | A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol | COMPLETED | PHASE3 |
| NCT01730053 | Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II) | COMPLETED | PHASE3 |